patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · antibody
lecanemab
Marketedupdated 2mo agoby Eisai Co Ltd🔗 ChEMBL
Approvedannual revenue · 2024–2024peak $231M
community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for 3 indications.
indications
investigational
Alzheimer's Disease
targets
Amyloid-beta precursor protein
all catalysts(8)
approval · 8
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that